Label: VRMX 500- pyrantel pamoate tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated February 6, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • ACTIVE INGREDIENT

    Active ingredient (in each uncoated tablet)

    Pyrantel Pamoate USP 180 mg (equivalent to 62.5mg of pyrantel base)

  • PURPOSE

    Purpose

    Antihelmintic

  • INDICATIONS & USAGE

    Use: for the treatment of pinworms

  • WARNINGS

    Warnings: Do not exceed recommended dosage

    Ask a doctor before use if:

    • you're pregnant
    • you're nursing a baby
    • you have liver disease

    When using this product: abdominal cramps, nausea, vomiting, diarrhea, headache, or dizziness sometimes occur after taking this drug. If any of these symptoms persist consult a doctor.

    Keep out of reach of children. In case of overdose, get medical help or contact a poison control center rightaway.

  • DOSAGE & ADMINISTRATION

    Directions:

    Adults, children 12 years of age and over, and children 2 years to under 12 years: Oral dossage is a single dose of 5 mg of pyrantel base per pound or 11 mg of pyrantel base per kilogram of body weight. Do not Exceed 1 gram (1000mg). Children Under 25lbs. or 2yrs: Don't use unless directed by a doctor.

    READ PACKAGE INSERT CAREFULLY BEFORE TAKING THIS MEDICATION

    WeightDosage (taken as a single dose)
    Less than 25 lb. or under 2 yrs. oldDo not use unless directed by a doctor
    25-37 lb.2 tablets
    38-62 lb.4 tablets
    63-87 lb.6 tablets
    88-112 lb.8 tablets
    113-137 lb.10 tablets
    138-162 lb.12 tablets
    163-187 lb.14 tablets
    188 lb & over16 tablets

  • STORAGE AND HANDLING

    Other information:

    • store at 15°-30°C (59°-86°F)
  • INACTIVE INGREDIENT

    Inactive ingredients: Colloidal silicon dioxide, croscarmellose sodium, crospovidone, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, potassium sorbate, talc.

  • OTHER SAFETY INFORMATION

    TAMPER-EVIDENT: DO NOT USE IF THE BLISTER IS CUT OR BROKEN

  • SPL UNCLASSIFIED SECTION

    Exclusively distributed by

    OPMX

    Chula Vista, CA 91910

    Questions or comments:

    619-600-5632

    MADE IN INDIA

  • PRINCIPAL DISPLAY PANEL

    NDC 69729-141-10

    VRMX 500

    Pyrantel Pamoate Tablets 180 mg

    TREATMENT FOR PINWORMS

    • Recommended By Health Care Professionals ForThe Entire Family

    ​10 Tablets

    carton

    blister

  • INGREDIENTS AND APPEARANCE
    VRMX 500 
    pyrantel pamoate tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69729-141
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PYRANTEL PAMOATE (UNII: 81BK194Z5M) (PYRANTEL - UNII:4QIH0N49E7) PYRANTEL180 mg
    Inactive Ingredients
    Ingredient NameStrength
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    CROSPOVIDONE (UNII: 2S7830E561)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)  
    POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    TALC (UNII: 7SEV7J4R1U)  
    POLYETHYLENE GLYCOL 6000 (UNII: 30IQX730WE)  
    Product Characteristics
    ColoryellowScoreno score
    ShapeROUNDSize13mm
    FlavorImprint Code G
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:69729-141-101 in 1 CARTON06/10/2022
    110 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02406/10/2022
    Labeler - OPMX LLC (029918743)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!